ALZN icon

Alzamend Neuro
ALZN

Overview Fund Activity

14 hedge funds and large institutions have $335K invested in Alzamend Neuro in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
-8
Holders Change %
-36.36%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
12
Calls
$79K
Puts
–
Net Calls
+$79K
Net Calls Change
+$59K

Top Buyers

1
HF
HRT Financial
New York
$15K
2
Geode Capital Management
Geode Capital Management
Massachusetts
$48.2K
3
Renaissance Technologies
Renaissance Technologies
New York
$9K
4
UBS Group
UBS Group
Switzerland
$1.7K
5
TRCT
Tower Research Capital (TRC)
New York
$2.95K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
$69.9K
2
Northern Trust
Northern Trust
Illinois
$0
3
Charles Schwab
Charles Schwab
California
$0
4
Bank of New York Mellon
Bank of New York Mellon
New York
$0
5
IIC
Integrated Investment Consultants
Michigan
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
XT
26
XTX Topco
Cayman Islands
– -$3.08K -10 Closed
IWS
27
Insight Wealth Strategies
California
– -$2.37K -7 Closed
IA
28
IFP Advisors
Florida
– -$1.19K -4 Closed
Fidelity Investments
29
Fidelity Investments
Massachusetts
– -$64 – –
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
– -$12 – –
1
2